Final Report Sero Survey0409
Final Report Sero Survey0409
Final Report Sero Survey0409
HEALTH DEPARTMENT,
HARYANA
Integrated Disease Surveillance Programme 1
Health Department, Haryana.
Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in
Haryana, India: a Population-Based Cross Sectional
Study
August 2020
&
This Serological Survey study for COVID-19 in the State of Haryana could not have been
possible without the support of Hon’ble Health Minister, Haryana, Worthy Additional Chief
Secretary to Govt. of Haryana, Health Department, Director General Health Services Haryana and
Department of Community Medicine & School of Public Health PGIMER, Chandigarh. I
would like to thank Sh. Anil Vij, Hon’ble Health Minister, Haryana for his unprecedented
support in all kind of acitivites and public health interventions required in the State especially
for the prevention and management of COVID-19.
My sincere gratitude goes to Sh. Rajeev Arora IAS, Additional Chief Secretary to Govt. of Haryana,
Health Department for providing me all necessary guidance and exceptional support. I also appreciate
all support and contribution provided by Dr. Suraj bhan Kamboj, Director General Health
Services Haryana. His guidance and advice helped me continuously during this Sero Survey.
My special thanks and gratitude to Dr. Arun Aggarwal, Professor, Department of Community
Medicine & School of Public Health, PGIMER, Chandigarh for being the main architect of
this serological survey study. I am deeply thankful to him and his team for providing all
technical assistance.
I would like to use this opportunity to thank Dr. Krishan Kumar, Deputy Director (IDSP),
Dr. Suresh Kumar Bhonsle, State Nodal Officer (IDSP) and Dr. Dolly Ghambhir, Additional
Senior Medical Officer (IDSP) and other officials of State IDSP Team who worked so hard
day and night to get this herculean task completed well in time. The officers who travelled
across the State to supervise the field activity during adverse weather conditions also need to
be applauded.
At last but not the least, I would like to thank all the Civil Surgeons of the State and their
dedicated teams of Doctors, Supervisors, Microbiologists, Lab Technicians, ANMs and others
from core of my heart who did the real ground work of sampling and testing at district level
despite the adverse weather conditions like heavy rains in most part of the State during the
survey. I again extend my special gratitude to all Microbiologists and Lab support Staff who
worked day and night to conduct the tests and upload the data on portal in a timely manner.
PGIMER Chandigarh team did planned the project, provided training using digital tools, monitored and
mentored the district and state teams, developed and executed quality assurance mechanisms, did data
analysis and report writing. State health department provided all resources including human resources,
laboratory logistics, and overall leadership for execution of such massive survey. All data collection was done
by the district teams. All laboratory testing was done by the district laboratories.
Overall seropositivity in the state was 8%. There was huge district wise variation. Prevalence 25% in
Faridabad, 20% in Nuh. Four districts had prevalence between 10% to 13%. Eight districts had prevalence
between 5-10%. There were rural-urban variations and male female variations within the districts. For
example, In Faridabad prevalence was 22% in rural areas and 31% in urban areas. In Nuh, it was 14% in rural
and 30% in urban areas. In Gurugram prevalence was 14% among females and 7% among males, in Hisar it
was 6% among males and 2% among females, In Nuh, it was 19% among females and 21% among males and
in Panipat it was 6% among females and 1% among males.
Seropositivity observed in the survey need to be interpreted with caution. There was no external quality
control for laboratory testing. Although, use of mobile app, that forced to capture GPS locations, and that
clusters were pre-selected by us, gives assurance that sample was representative; however, with the
observation that one district had started the sampling before the official launch of the project, raises question
on the representativeness of the survey in that district. Furthermore, for estimation of true prevalence, validity
of the ELISA test used in the survey needs to be factored.
Arun K Aggarwal
Professor
Email: [email protected]
Background………………………………………………………………………………………..7
Aim………………………………………………………………………………………………..8
Methodology………………………………………………………………………………………8
Sampling Framework……………………………………………………………………………...9
Training at State & District Level………………………………………………………………..13
Launch of Sero-Survey…………………………………………………………………………..14
Quality Assurance………………………………………………………………………………..22
Annexure 1 Role of Department of Community Medicine & School of Public Health and role of
Director General Health Services, Haryana…………………………………………......……….23
Annexure 2 STANDARD OPERATING PROCEDURE (SOP) ………………………………..25
Participant Information Sheet……………………………………………………………………27
Survey Form as on Mobile APP…………………………………………………………………32
District Kaithal………………………………………………………………………………...…83
District Karnal……………………………………………………………………………………87
District Kurukshetra………………………...……………………………………………………91
District Mahendragarh……………………….…………………………………………………..95
District Rewari………………………………………………………………………………….117
District Rohtak………………………………………………………………………………….121
District Sirsa…………………………………………………………………………………….124
District Sonepat…………………………………………………………………………………128
District Yamunanagar…………………………………………………………………………..132
Sero Testing Results……………………………………………………………………………135
****************************************************************
Corona virus disease 2019 (COVID-19) is a recently emerged infectious disease caused by novel corona
virus. It is also called as the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2).It is an
ongoing pandemic which originated from Wuhan City of Hubei Province of China and spread rapidly to the
rest of the world (1). The World Health Organization (WHO) has declared this disease as a public health
emergency of international concern. Till 29th July 2020, 16558289 cases of COVID-19 and 656093 deaths
have been reported globally (2).
Seeing at the current scenario of pandemic spread of this disease which has entered in to community
transmission phase in each country, research is not only focused on the development of treatment and
preventive (vaccine) strategies but huge efforts are also being made to estimate the exposure of population by
conducting seroprevalence studies (3,4,5 &6). Due to the high proportion of asymptomatic or mild infections,
data restricted to laboratory-confirmed cases do not capture the true extent of the spread or burden of the virus
in a population. Therefore, serological detection of specific antibodies against SARS-CoV-2 can better
estimate the true number of infections. From the rest of world seroprevalence data have started to emerge
(3,4,5) but from India, seroprevalence data is not available yet. Only recently a report is published from Delhi
about 11 districts which showed the seroprevalence of 23% and similarly a report from Mumbai reported
seroprevalence 33%. Since this limited unpublished data cannot represent the seroprevalence status for whole
country, therefore state wise seroprevalence surveillance is a need of the hour. Hence on the proposal of
Haryana Govt state-wise seroprevalence study was done to the estimate the prevalence of anti-covid IgG
antibodies in the state.
To undertake the community based state level sero-surveillance to monitor the exposure of general population
to SARS-Cov2 infection in Haryana and to establish such system for future monitoring
Objective:
Methodology
Study design was cross sectional with stratified multi-stage random sampling.
Sample Size: Sample size was estimated at district level. With expected prevalence (p) of 3%,
absolute precision of 2% (1-5%), 95% confidence level, design effect 3, sample size came out to be
839. (~ 850) per district. So it was planned to cover 850 participants from each district.
Sampling Design: Stratified multistage random sampling was done. Total sample of 850 was
divided into two stratas: Rural and Urban. Since Haryana state has ratio of rural to urban is roughly
60: 40, so these 850 participants were divided into two clusters: 500 Rural and 350 Urban.
To achieve this, multistage sampling was done. In first stage, from each district four PHCs were
selected using simple random sampling using random numbers generated from computer. In second
stage from each PHC, one Sub-centre was selected using simple random sampling using random
numbers generated from computer. In third stage, one non SC village was selected randomly by
lottery method. For SCs, where there was no non-sub-centre village, an adjoining non sub-center
village was selected randomly. As a sub-centre is also located within each sub-centre, while
selecting sub-centre village, such PHC level sub-centres were excluded from the sampling.
Each of PHC village, Sub-centre village and non-sub-centre village constituted a cluster. Thus there
were 12 clusters for rural areas per district. Sample size per cluster was about 44. Detail of clusters
that were selected is given in table 1. For urban areas, total sample of 350 was divided into four
clusters, with sample size of about 88 per cluster. Detail of selected urban clusters is given in Table
2. District wise detail of actual sample size achieved in various clusters is given under results in
household survey section.
Each selected cluster was geographically divided into roughly four quadrants. Local maps available
with the districts were used. Some districts used Google maps for the same. Middle of each quadrant
will be marked on the map or with the GPS location. Thus, four random GPS locations in each
cluster were selected and shared with the survey teams. Survey teams visited consecutive houses
from this point till required sample size for that location was completed. It was 11 houses per GPS
location in each cluster in rural cluster and 22 in urban cluster.
The above methodology was chosen to maintain uniformity and comparability with the guidelines
adopted during national level sero-surveillance that was done in the recent past.
For sake of clarity, on demand of the districts, above table was extended for adults more than for,
and women more than four as given below:
5 6 7 8 9
2 Oldest Man Oldest Man Oldest Man Oldest Man Oldest Man
3 Oldest Man Oldest Man Oldest Man Oldest Man Oldest Man
9 x x x x Oldest Woman
Study duration: Study was planned for Two months. However, on the insistence and initiative of
the state study was completed in One month’s time from conceptualization of the project till
submission of this report.
Exclusion Criteria: Age blow 18 years, person with current influenza like illness and person who
did not give consent.
Study Methods
Study Team:
For each cluster there was one team constituting of one medical officer, one HCW of ANM/ LHV
level preferable of the selected health facility, and one laboratory technician or trained phlebotomist.
There was one supervisor for 2 clusters. These teams were constituted by the districts under the
direction of the state.
Training: Study team was given training using digital mode about the following:
State had created two Whatsapp groups with about half the districts in each group. Two digital
trainings were organized. State organized these trainings using Jio app meeting application. In first
training, we oriented the team to all 8 points as mentioned above. They were introduced to the data
collection tool prepared in mobile based app surveyman.ankaha.com. Screenshots of the tool were
presented in power-point.
Followed by this, all surveyors and supervisors were helped to download the mobile app, register on
the app and see the survey form on their mobile phones.
After this, a second training was done to give live demonstration of the mobile app to them.
State had informed us that a basic training has already been given by the concerned districts and
state on the laboratory procedures. However refresher training was done to bring everyone on the
same page.
The study teams visited the randomly selected households and briefed them about the survey. For
each house, basic information on Age and sex of each family member was recorded. Verbal consent
was taken for their willingness to participate in the study. Study teams were given audio recording
by the PI, on how to take consent, so that it can refresh the skills of the surveyors on taking consent.
Even this could use by the surveyors directly in case they feel hesitant in speaking out. All SOPs are
given in the Annexure 2.
One consenting adult was included in the study. For consenting adults, team filled the questionnaire
and recorded information on basic demographic details, exposure history to lab confirmed COVID-
19 cases, symptoms suggestive of COVID-19 in the preceding month, and clinical history. Doctor in
the team was supposed to ask the questions and the other person was supposed to record the form. At
the end of interview, doctor was supposed to cross check the form for its completeness and
correctness. At the end of the interview, laboratory technician drew 3ml blood, labeled it and
transported to the district lab for storage and processing.
After completing one house, team ensured that the bleeding from the punctured site has stopped.
Swab that was used to stop bleeding was collected by the team along with other biomedical waste
that was generated in the house. If required a fresh swab was applied for psychological satisfaction.
Team completed one GPS location point in the cluster and then moved to the next point. One cluster
was supposed to be completed in one day in both rural and urban areas. All districts completed all
the clusters within 3 days despite heavy rains in many districts on the first day.
At the end of sample collection from the cluster, all samples were immediately transported to the
designated laboratory for processing.
ELISA: ELISA kit and methodology generated for estimation of IgG antibodies was used as per
guidelines of ICMR (7). All data was entered in an android mobile application
sureyman.ankaha.com. Analysis of data and results was done to give the estimates of seroprevalence
at district and state level. Exploratory results are also presented to give positivity rate area wise
(Rural/ Urban), and Gender-wise (Male/Female). District wise and cluster-wise sero positivity has
also been given in this report.
Expected outcome: The population based sero-epidemiological study has helped to determine the
burden of COVID 19 infection at the community level in the state of Haryana.
Since state is undertaking Sero-surveillance as part of the national guidelines and districts are
supposed to do this in routine to take evidence based public health actions, Institute Ethic
Committee’s tentative approval of exemption was obtained. This type of surveillance is exempted
from the ethics committee approvals.
Participants were informed about the study objectives, importance of the survey, and interpretation
of positive result. Informed verbal consent was administered. They were free to participate or refuse.
As laboratory result has now become available, after the state approves the report, district nodal
persons will communicate results on phone and will counsel the participant to take further actions as
per the guidelines.
On 6 August, 2020 all the DSOs, Microbiologist and Medical Officers in-charges participated in
the online training. Information of detailed Sero Survey study was given. Information of District
wise distribution of clusters and division of clusters in Quadrant was given. Distribution of team
members and supervision of the team was also explained. Demonstration on use of Elisa Kits
was given by technical team.
b) On 10th August, 2020 online Launch cum Review Meeting of Sero Survey.
On 10 AUGUST, 2020 online LAUNCH of Sero Survey was held under the chairmanship of
Hon’ble Health Minister Sh. Anil Vij. On this Occasion Worthy ACS Sh. Rajeev Arora gave
information on Sero Survey. Presentation on Sero Survey was given Dr Usha Gupta DHS(IDSP).
Launch of Sero Survey by Sh. Anil Vij, Hon’ble Health Minister, Haryana on 10thAugust 2020
c) Online Training on Sero Survey with Collaboration with Department of Community Medicine
and School of Public Health PGIMER, Chandigarh on 11th August, 2020. Training was given to
DSOs, District Supervisors, Nodal officers and Medical officer of Sero Survey team.
Sero Survey Training through VC by Dr Usha Gupta, Director Health Services (IDSP) & Dr.
Arun Aggarwal, Professor, Community Medicine and SPH, PGIMER, Chandigarh
e) Training to State RRT Members on 18th August, 2020 by Dr. Usha Gupta.Details of the Sero
Survey study was explained. Information regarding app-based tool, clusters of the all the
Districts, forms and formats were given. Information about what and how to supervise the
clusters was also given.
Sero Survey Training to State RRT Members by Dr Usha Gupta, Director Health Services
(IDSP) On 18 August, 2020
On 17th of August 2020 Pilot testing was done in Panchkula District. Briefing of it was done in the
evening through Video Conferencing. Explanation and solutions were given by Dr. Arun Aggarwal
Prof. Community Medicine and SPH on issues faced by the team during the cluster activities. Points
observed by the PGI supervisors were also discussed and corrective action for it was taken. The
participants of the VC included DHS IDSP, CMO Panchkula, NO, District supervisors, Medical
officers and other staff of State IDSP cell and PGI Team.
After reviewing the activity in Panchkula Survey was initiated in all the 20 Districts on the
19th of August 2020. On 19th August field activity started with the collection of blood samples from
the households in the clusters as per the protocol. The Activity of Sero survey was supervised by
State IDSP supervisors, State RRT members at State level and District level by Deputy Civil
Surgeon and Senior Medical Officers. At the end of the day collected samples stored in the required
temperature were transported to lab of the respective Districts. In the lab collected samples of the
participants were processed. Activity in clusters was completed on 21st August 2020. More than
18,700blood samples were collected and processing of it was done in the laboratory.
Non SC
District PHCs SCs SC Village Pop Pop
Village
1 1 P1 PHC village R1
2 P1S1 SC village R2
3 P1S1V1 NSC Village R3
4 P2 PHC village R4
5 P2S2 SC village R5
6 P2S2V2 NSC Village R6
2 1 P3 PHC village R7
2 P3S3 SC village R8
3 P3S3V3 NSC Village R9
4 P4 PHC village R10
5 P4S4 SC village R11
6 P4S4V4 NSC Village R12
3 1 U1 Urban U1
2 U2 Urban U2
3 U3 Urban U3
4 U4 Urban U4
5 Backup
6 Backup
The original Gantt chart that was approved is given below. However, after first two weeks of
planning, training and preparedness, state decided to speedup. Against the one week decided for the
pilot survey in one district, it was decided to do the pilot for one day 17 th August. However, it
discovered that the pilot district has collected most of the samples before the day of the pilot.
Similarly, against the planned staggered survey to be completed in two weeks; one week for half the
districts and another week in pending districts, state decided to do the surveys in all districts in one
go. However, state assured to nominate the external supervisors in all the districts such that on the
first day of the survey, there should be atleast one supervisor in each district.
August September
Quality assurance was an important feature of this mammoth survey. Five systems were
implemented for this:
1. In the mobile based survey tool, a question was introduced towards the end that forced the
doctor in the survey tool to check the collected data for completeness and correctness before
saving the forming.
2. There was one supervisor for two teams. They were supposed to visit atleast 10% of the survey
houses, that means 1-2 houses per quadrant in rural clusters and double of that in the urban
clusters. They were supposed to fill the supervisory forms using the mobile app and they were
supposed to capture the SPS location of the visit.
3. Supervisors from the state head quarter or nominated by them from various medical colleges
were also supposed to record the entries on the mobile app.
4. Supervisors from the Department of Community Medicine & SPH of PGIMER Chandigarh
made independent visits. The supervisory report from this team is included in this report as
Annexure 3.
5. As data was being captured in real time, the team under lead of PI, made monitoring and
evaluation calls to the medical officers and the families to first mentor the team and secondly
cross check if the family has been visited and if consent was taken and the experience with the
blood sampling.
There was no direct financial liability on the institute except that 3 weeks of extensive
consultation work was done for the state by the PI and his support team.
1. Deployment of Human Resources. It was done as per the plan to large extent.
a. 6 Teams per District. One team with one medical officer, one laboratory technician and
one ANM/ LHV/ or any other staff of this level.
b. 3 supervisors per district: one supervisor per 2 teams. These may be from any
supervisory cadre with good attitude
c. One State level supervisor for every two districts to be covered on one day.
2. Logistics: Forms were printed, digital tool was used on the android mobile phones. Other
logistics were available. Following plan was given to the districts.
a. Forms and formats: 850 forms will be required per district. Including wastage, get 1000
forms printed per district
b. Digital data entry logistics in terms of mobile phone or some Pad should be made
available to all teams.
c. State/ district will provide maps of the selected clusters for further micro-planning
d. Laboratory materials in terms of blood withdrawing supplies (syringes/ needs/
vacutainers), cotton swab rolls, 70% alcohol for swab, bar code readers, barcode
generator, bar code printed slips (4 slips per participant: one for blood vial/ vacutainer/
one to be pasted over survey form, and third on the laboratory document, and fourth
extra).
e. Permanent black pen markers with fine Tips (two per team).
f. Laboratory materials for storage and transport.
g. Biomedical waste management supplies (Yellow bags, Black bags, Puncture proof leak
proof transluscent containers, Stickers of BMW hazard and label stickers).
h. Functional ELISA machine with related materials.
3. Transportation: State and districts arranged the vehicles as per the following plan given to
them, except that one vehicle was available for Panchkula for two days, and that 4 vehicles
4. Lodging & Boarding: Could not be used as all districts were started at one go for the survey.
a. State will be responsible for all lodging and boarding of state level supervisors (2
persons from PGI team and 4 persons from State DGHS office).
b. State will ensure all arrangements related to regular meals and refreshments of the
visiting teams.
5. Communication: State established two whatsapp groups that worked exceptionally well to
solve the issues of the districts in real time. The team of PI and state HQ were available from
early morning to midnight to the district teams and to the state. Two nodal officers from state
were designated by Director IDSP. Following was expected from the state:
a. State will establish all communication systems required for liaising with the teams
throughout the state.
b. State should fix nodal persons for state and for each district for such purpose.
7. Administrative Support and Police Protection: It was expected that this being sensitive
matter, state will ensure through District Administration, that adequate police protection is
provided to each team through-out the survey period. It seems that district administration was
informed, however no police protection was deployed.
8. Local Guides and Escorts to Supervisors: It was expected that state will ensure to provide
local guides and police escort to each of the state supervisory team. However, the work could
be accomplished without this.
1. Purpose: This SOP describes the procedure for Sero-surveillance for COVID-19 for Haryana
2. Scope: This SOP is intended for use by trained health staff or personnel who would be
conducting antibody testing for COVID-19 by ELISA, using intravenous blood from the study
participants.
3. Roles and Responsibilities: Trained health staff or personnel will be responsible for verbal
consent, history elicitation, IV blood withdrawal, blood collection, transportation and testing for
antibodies for COVID-19.
5. General precautions
The personnel performing interview and drawing blood should wear appropriate PPE
Universal precautions should always be followed during collection and processing of blood
specimen
Laboratory accidents and injuries should immediately be reported to designated supervisory
staff/lab director/hospital authority
Bio-waste should be managed and disposed in accordance with national guidelines
This test is not diagnostic; it tells if there is already developed immunity against COVID-
19.Positive result: Consult doctor for interpretation. If symptomatic, consider RT-PCT testing
(Complete quarantine; if already in quarantine) If non-symptomatic, observe social distancing
and cough etiquettes .Negative result: Observe social distancing and cough etiquettes.
Namaskar!
We are from Health Department Haryana. We have come on behalf of Health Department of
Govt. of Haryana to do a survey. Can we speak to you now?
If yes, then sit at a place offered by family. Make sure neighbor do not crowd and surround you.
1. Purpose of the study: You know that a new infection COVID-19 has occurred worldwide
including India and Haryana. Because of this all of you are staying at home since March this
year. We appreciate your co-operation to follow the instructions given to you time to time. In
order to better serve you, Haryana Govt. wants to know how many people have already suffered
from this context. It has been observed that lot of people get the infection but do not get the
signs and symptoms. It means they donot develop any cough/ cold/ fever etc. Or it may be so
mild that it goes unnoticed. However, now blood tests are available that can tell if you had got
this infection in recent past. If your blood test will come out to be possible, it may be a good
news to you. It may mean that you got the infection, but did not suffer, and that in future you
will be able to fight this infection strongly.
Thus purpose of this study is to know how many people in your area have already suffered from
the infection of COVID-19. The knowledge gained might help the program managers to evolve
guidelines to help prevent and control the spread of infection in communities in future.
2. Procedures: If you agree to participate in this study, then we will ask you few questions about
your personal and family background, household details, exposure history and any significant
medical history of co-morbidities. We will take 5 ml of blood from your suitable vein in the
arm, taking all precautions to cause minimum discomfort to you. Blood test will be done in the
laboratory for presence of antibodies against COVID-19. The interview, blood collection will be
followed by take about 15 minutes of your time. We sincerely request you to give us that time
and participate in the survey.
3. Risk of participation: You may experience some discomforts while participating in this study.
During the interview for data collection, you may have emotional discomfort while recollecting
the circumstances under which the contact/exposure to COVID 19 case might have taken place.
If needed, we will direct you to the Government operated telephonic psycho-social support
facility where trained counselors will answer your questions and suggest help.
4. Benefit of Participation: Your blood test report will benefit you in terms of the information
about your exposure status. There is no other financial or in kind benefit of participation.
5. Participant’s Rights: Taking part in this study is voluntary. You can choose not to take part.
You can choose not to answer a specific question. You can also stop answering these questions
at any time without having to provide a reason. This will not affect any of your rights including
right to seek care in a Government facility.
7. Compensation: No compensation will be paid to you for taking part in this study.
8. Contact details: If you wish to find out more about this survey, you can ask me all the
questions you want and seek clarifications. You can contact ………………………..
(District Nodal Officer) for further queries.
नमस्कार!
यवि हााँ , तो पररिार द्वारा िी गई जगह पर बैठें।सुवनवित करें वक पडोसी और भीड आपको घेर न लें।
1. अध्ययन का उद्दे श्य :आप जानते हैं वक भारत और हररयाणा सवहत िु वनया भर में एक नया संक्रमण कॉविड-
19 हुआ है । इस िजह से आप सभी इस साल मार्च से घर पर ही रह रहे हैं । हम समय-समय पर आपको विए
गए वनिे शों का पालन करने के वलए आपके सहयोग की सराहना करते हैं । आपकी बेहतर सेिा करने के
वलए, हररयाणा सरकार। यह जानना र्ाहता है वक वकतने लोग इस संिभच से पहले ही पीवडत हैं । यह िे खा
गया है वक बहुत से लोगों को संक्रमण हो जाता है ले वकन संकेत और लक्षण नहीं वमलते हैं । इस का अर्च है
वक िे वकसी भी खााँ सी/सिी /बुखार आवि का विकास नहीं करते हैं या यह इतना हल्का हो सकता है वक यह
वकसी का ध्यान नहीं जाता है । हालां वक, अब रक्त परीक्षण उपलब्ध हैं जो बता सकते हैं वक क्या आपको हाल
के विनों में यह संक्रमण हुआ र्ा। यवि आपका रक्त परीक्षण संभि हो जाएगा, तो यह आपके वलए एक
अच्छी खबर हो सकती है । इसका मतलब यह हो सकता है वक आपको संक्रमण वमला है , ले वकन पीवडत नहीं
हुआ, और भविष्य में आप इस संक्रमण से दृढ़ता से लड पाएं गे।
इस प्रकार इस अध्ययन का उद्दे श्य यह जानना है वक आपके क्षे त्र में वकतने लोग पहले से ही कॉविड - 19 के
संक्रमण से पीवडत हैं । प्राप्त ज्ञान कायचक्रम प्रबंधकों को भविष्य में समु िायों में संक्रमण के प्रसार को रोकने
और वनयंवत्रत करने में मिि करने के वलए विशा वनिे श विकवसत करने में मिि कर सकता है ।
2. प्रवक्रयाएं :यवि आप इस अध्ययन में भाग ले ने के वलए सहमत हैं , तो हम आपसे आपकी व्यक्तक्तगत और
पाररिाररक पृष्ठभू वम, घरे लू वििरण, जोक्तखम इवतहास और सह-रुग्णता के वकसी भी महत्वपूणच वर्वकत्सा
इवतहास के बारे में कुछ सिाल पू छेंगे। हम आपकी उपयुक्त नस से 5 वमली लीटर रक्त ले गें, वजससे आपको
कम से कम असुविधा हो सकती है । कॉविड- 19 के क्तखलाफ एं टीबॉडी की उपक्तथर्वत के वलए प्रयोगशाला में
रक्त परीक्षण वकया जाएगा। साक्षात्कार, रक्त संग्रह आपके द्वारा लगभग 15 वमनट का समय वलया जाएगा।
हम आपसे वनिेिन करते हैं वक आप हमें िह समय िें और सिेक्षण में भाग लें।
3. भागीिारी का जोक्तखम :इस अध्ययन में भाग ले ने के िौरान आपको कुछ असुविधाएाँ हो सकती हैं । डे टा संग्रह
के वलए साक्षात्कार के िौरान, आपको उन पररक्तथर्वतयों को याि करते हुए भािनात्मक असुविधा हो सकती है
वजन के तहत कॉविड- 19 मामले में संपकच /संपकच हो सकता है । जरूरत पडने पर हम आपको सरकार द्वारा
संर्ावलत टे वलफोवनक साइको- सोशल सपोटच सुविधा प्रिान करें गे, जहां प्रवशवक्षत का उं सलर आपके सिालों
का जिाब िें गे और आपकी मिि करें गे।
4. भागीिारी का लाभ :आपकी रक्त परीक्षण ररपोटच आपको अपने जोक्तखम की क्तथर्वत के बारे में जानकारी के
मामले में लाभाक्तित करे गी। भागीिारी के वलए कोई अन्य वित्तीय या ियालु लाभ नहीं है
6. गोपनीयता और गोपनीयता :हम उस कवठन समय को समझते हैं वजसका आप सामना कर रहे हैं । आपकी
पहर्ान और व्यक्तक्तगत जानकारी की सुरक्षा के वलए उवर्त िे खभाल की जाएगी। एक प्रवशवक्षत
साक्षात्कारकताच द्वारा एक संरवर्त साक्षात्कार अनुसूर्ी का उपयोग करके आपका डे टा एकत्र वकया जाएगा।
हम कोरोना िायरस के क्तखलाफ एं टीबॉडी का पता लगाने के वलए रक्त के नमू ने एकत्र करें गे।आपके नमू नों
को कोड संख्याओं का उपयोग करके संसावधत वकया जाएगा। बर्े-खुर्े नमू नों को भविष्य के शोध के वलए
संरवक्षत वकया जाएगा। प्रयोगशाला के पररणाम अध्ययन िल को विए जाएं गे और अध्ययन डे टा बेस में िजच
वकए जाएं गे। परीक्षण ररपोटच में उस पर आपका नाम नहीं होगा।
हम प्रासंवगक डे टा एकत्र करने का प्रस्ताि करते हैं वजसमें सामावजक-जनसां क्तख्यकी, कॉविड- 19 रोवगयों के
सार् संपकच के जोक्तखम वििरण शावमल हैं । आपसे संबंवधत डे टा का उपयोग केिल िैज्ञावनक उद्दे श्यों के वलए
वकया जाएगा और गोपनीयता बनाए रखने के वलए आपके ररकॉडच को सुरवक्षत रूप से रखा जाएगा।
7. मु आिजा :इस अध्ययन में भाग ले ने के वलए आपको कोई मु आिजा नहीं विया जाएगा।
8. संपकच वििरण :यवि आप इस सिेक्षण के बारे में और अवधक जानकारी प्राप्त करना र्ाहते हैं , तो आप मु झसे
िे सभी प्रश्न पूछ सकते हैं जो आप र्ाहते हैं और स्पष्टीकरण र्ाहते हैं । आप आगे के प्रश्नों के
वलए……………………… .. (वजला नोडल अवधकारी (से संपकच कर सकते हैं ।
1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health
concern. Lancet. 2020. https://doi.org/10. 1016/S0140-6736(20)30185-9.
2. Coronavirus disease 2019 (COVID-19). Situation Report – 191, 2020. WHO.
3. StringhiniS, Wisniak A, Piumatti G, Andrew S Azman et al. Seroprevalence of anti-SARS-
CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
The Lancet (2020).
4. Eckerle I, Meyer B. SARS-CoV-2 seroprevalence in COVID-19 hotspots. Lancet.
5. 5.Fiona P. Havers, Carrie Reed, Travis Lim et al. Seroprevalence of Antibodies to SARS-
CoV-2 in 10 Sit in the United States, March 23-May 12, 2020. https://jamanetwork.com/ on
07/30/2020.
6. Banaji M. What Do the Delhi and Mumbai Sero-Survey Results Tell Us About COVID-19 in
India? Scinence the Wire. July 2020.
7. List of Companies / Vendors of Rapid Antigen Test Kits for COVID-19 validated/ being
validated by ICMR.
https://www.icmr.gov.in/pdf/covid/kits/List_of_rapid_antigen_kits_28072020.pdf
S_Opt_
Qn_
Qn S_Qn Opt_Name Type
Name
In
PanchkulaCluste Cascadi
Enter Name of
rs_newDinesh.c ng
District Cluster and 2
sv,Haryana Dropdo
Family Number
Clusters.csv wn
Short
ELISA report 7
Text
Date-17/08/2020
Area Visited: Civil Hospital lab, Panchkula, Sector-19, Panchkula (Urban cluster); Toda (rural
cluster)
Observations
1. Laboratory had all the required facility for processing the sample.
2. Designated place was allotted specifically processing the sero survey samples.
3. Required equipment was working and methodology as per kit is being used.
4. Sample record is maintained properly.
5. Team was encouraged to fill the lab results in the app.
6. The area was divided into four quadrants and mid area was selected from center/ sub-center
map by medical officer.
7. The selection of member was appropriate and from the designated table only.
8. Full team ANM, lab technician and medical officer was present at the site.
9. Members were filling hard copy of form first and mobile app after that- Advised to fill
mobile app form first, to prevent mismatching of data and collected sample.
10. One designated place near to quadrant was fixed to take the sample- which is acceptable as
per covid-19 safety issue and space constrains issue. Advised to fill house location in app at
house only, other information and sample can be taken from designated site only.
11. Informed consent was taken prior to sample collection
12. LT was withdrawing blood under aseptic conditions
13. Biomedical waste segregation was according to the guidelines only
14. Labeling of blood was proper.
15. Demand by team for multiple access to the survey manger was raised.
Supervisors:
Dr. Vivek Sagar &Dr. Anuradha Nadda, Deptt. Of Community Medicine & SPH PGIMER,
Chandigrah
Cluster Visit
As per MO’s they had been instructed to sample households randomly, however the
technique for random sampling was varying. The rule of left (turn) was not specified.
Adhar ID and ration card details were being additionally recorded (Mudlana, Bhainswal
Kalan) as directed in dist. Sonipat survey briefing.
Though the microplan for Day 1 (19-Aug-2020) stated – Mahara PHC; Barswani was being
sampled instead on Day 1. MO’s were apparently allowed to make their 3-day micro-plans.
The MO of Mahara had chosen to start with Barswani -day 1, Hulleri -day 2 and Mahara -day
3.
MO’s took detailed consent after explaining study (Mudlana, Barswani(; MO at Bhainswal
Kalan detailed the study purpose to respondent in one observation but not a second instance
stating that the subject was AWW and knew about study already.
Only 4 samples had reached at time of visit (4 PM), as it was day 1 of data collection, and
collection was in process. No samples was tested at time of visit as samples from other
clusters were awaited.
Samples were correctly labelled, and properly stored.
Cold chain was maintained.
Register was properly maintained.
Medical Officer at Bhainswal Kalan filling out hard-copy and mobile-based form
Date-19.08.2020
Observations
In all areas team was working hard despite rain. Teams were going house to house with so much
material, which is really appreciable and shows the motivation of all team members to fight against
Covid-19.
Cluster YNR03
1. Team started late, as it was raining heavily. Lab technician was in full PPE.
2. Biomedical waste disposal was not been properly
Rest everything was satisfactory.
Cluster YNR 01
Cluster KKR04
Survey was interrupted due to rain. Teams were working as per guidelines.
Date-19-08-2020
Cluster 1 (Kaithal)
1. Medical Officer was not trained, selection of participant in the household was not proper.
2. Biomedical Waste was good.
3. Informed Consent was taken.
4. The team was setting up the kiosk when I reached there
Cluster 2 (Kaithal)
1. Despite rains, 2 MOs, 2 SNs and 2 MPHWs were carrying out household survey.
2. Informed consent was not taken.
3. The selection of one household visited was not correct, however MO has told that it was by
mistake. And next household she did correctly.
4. Biomedical Waste Management was good but again patient was not told about disposal of
cotton after prick.
5. Cold Storage was adequate.
Table 3: Did the Family Give Consent for the Survey, Ambala?
Response Number Percent
No. 17 1.9
Yes 858 97.1
Blank 9 1
Total 884 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Ambala
(Multiple response)
Table 3: Did the Family Give Consent for the Survey, Bhiwani?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Bhiwani (Multiple
response)
Symptoms Number Percent
["No Symptom”] 729 84.5
["Body Ache", "Tiredness", "No Symptom] 1 0.1
["Body Ache", "Tiredness"] 1 0.1
["Body Ache"] 5 0.6
["Breathlessness"] 1 0.1
["Cough", "Running Nose"] 1 0.1
["Cough", "Tiredness"] 1 0.1
["Cough"] 1 0.1
["Fever", "Cough", "Running Nose"] 2 0.2
["Fever", "Cough"] 2 0.2
["Fever", "Stomach Ache"] 1 0.1
["Fever"] 3 0.3
["Headache", "Body Ache", "Tiredness"] 1 0.1
["Headache", "Body Ache"] 1 0.1
["Headache"] 5 0.6
["Running Nose"] 1 0.1
["Sore Throat", "Body Ache"] 1 0.1
["Stomach Ache"] 3 0.3
["Tiredness"] 2 0.2
["Any Other"] 1 0.1
Blank 100 11.6
Total 863 100
Table 3: Did the Family Give Consent for the Survey, Charkhi Dadri?
Table 7: Was there Any Health Problem in Last 30 Days, Charkhi Dadri?
Table 3: Did the Family Give Consent for the Survey, Faridabad?
Response Frequency Percent
No 12 1.5
Yes 794 98.1
Blank 3 0.4
Total 809 100
Village/Ward Number
Aajad Nagar Tohana 6
Adarsh Colony Bhuna Road Tohana 1
Ashok Nagar Ward No.5 FTB-14 7
Ashol Nagar, Ward No.5 1
Badi Hanuman MurtiTohana 1
Baliala Road Dhani 1
Balmiki Chowk BrootGaliTohana 5
Begampur Colony 1
Bhat Basti Tohana 1
Bhatia Colony 16
Bhatia Nagar 3
Bhattukalan 40
Bhattukalan 2 2
Blada Colony Tohana 1
Buta Shah Basti 6
Canal Road Bhatia Nagar 1
Chandigarh Road 3
Chaubara 41
Dher 43
Ekta Nagar Dhani Bhuna Road Tohana 1
Gali No. 5, Bhatia Colony, 1
Geeta Colony Dangra Road Tohana 1
Gilla Vali DhaniTohana 1
Gullarwala 44
Gupta Colony Tohana 1
Guru Ravidas Mohalla 1
Harijan Colony Ward No 14 (Q1) 15
Huda Polyclinic 88
Indira Colony Tohana 6
Jakahal 41
Jandli Kalan 41
Javahar Nagar Tohana 1
Kalyan Nagar 2
Kalyan Nagar Tohana 2
Kath Mandi, Ward No. 13 10
Khobra Mohalla Tohana 1
Killa Mohalla Tohana 1
Kirdhan 42
Krishna Colony Tohana 5
Lajpat Nagar Ward No 10 8
Maniana Road Ward 1 1
Masala Factory Damkora Road 2
Meyond 42
MpRohi 42
Table 3: Did the Family Give Consent for the Survey, Fatehabad?
Response Number Percent
No 23 3
Yes 750 96.9
Blank 1 0.1
Total 774 100
Village/Ward Number
Malibu Town 1
23 1
26 29
26 Tigra 1
30 23
39 1
Aklimpur 48
Anjan Colony 23
Badshahpur 48
Basai Enclave Part 2 24
Basai Enclave 1
Basai Enclave Part 1 26
Bhawani Enclave 22
Bhim Nagar 27
Bhorakalan 54
Bhudka 53
Daultabad 62
Grm16 Tigra 3
H. N 63 1
Inchapuri 50
Kadipur Industrial Area 26
Khandsa 43
Malibu 26
Mohammadpur 26
Mukesh 1
Nand Kishor 1
Narshingpur 6
Near BeragiChaupal Sarai Alawardi 6
Palra 57
Parbha 1
Parvati 1
Pataudi 15
Patel Nagar 85
Rathiwas 49
Sarai Alawardi 43
Sarai Sec 109 1
Tigra 15
VillSherpur 47
Village Bajgerha 57
Ward 05 Pataudi Near Shiv Murti 4
Ward 10 12
Table 3: Did the Family Give Consent for the Survey, Gurugram?
Response Number Percent
NO 49 4.7
Yes 999 95.2
Blank 1 0.1
Total 1049 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Gurugram
(Multiple response)
Village/Ward Number
Rishinagar 1
VpoUmra 1
Agroa 44
Bass 49
Bhatla 45
ByanKhera 43
Gianpura 49
Gol Kothi 22
Gurana 42
Jeetpura 20
Jyoti 1
Kharkara 45
Khokha 44
Kirmara 34
Kuleri 66
LuxmanChotraHansi 22
Mahavie Colony Hisar 88
Old 1
Old Rishinagar 45
Pate Nager 89
Ragaran Mohalla 7
Ram Lal Colony 22
Rattan Mohalla 1
Regar Mohalla 15
Rishi Nagar 55
Village Jeetpura 34
VpiUmra 1
VpoBhatla 1
VpoKirmara 9
VpoUmra 42
Total 938
Village/Ward Number
3 1
SilaniZalim 1
Netaji Nagar Bahadurgarh 1
Adarsh Nagar 5
Chhuchhakwas 44
Dhakal 42
Dharampura 2
Dhup Singh 1
Gali 10 Vikas Nagar 13
Gali No. 8 Sainik Nagar 22
Gijarod 31
Girdharpur 42
Gwalison 44
Jahazgarh 49
Jajjhar Rod 1
Jatwada Mohalla 19
Jiya Garden 1
Kaliram 1
Khatiwas 44
Kila Mohala 22
Maroth 43
MP Majara 44
Mukeah Kumar 1
Netaji Nagar 43
Omaxe City 8
Patel Nagar 10
Patel Park 1
Sec 2 4
Sec 6 Bahadurgarh 4
Sec 7 15
Sec 9 44
Sec-6 2
Shakti Nagar 10
Silani 7
SilaniZalim 19
SilaniKeaho 16
SuLodha 1
Subana 86
Uphc Netaji Nagar 39
Ward - 04 43
Ward -03 Vikas Nagar 33
Table 3: Did the Family Give Consent for the Survey, Jhajjar?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Jhajjar
(Multiple response)
Village/Ward Number
Alewa 44
Bhadurgarh 46
Durana 48
Durjanpur 45
Hathwala (JND 09) 43
Jnd-14-01 92
Jnd13q1 101
Julana 42
Kakdod 44
Katwal 44
NacharKhera 47
Patiala Chowk 72
Pauli 48
Polyclinic 82
Sant Nagar 18
Silla Kheri 47
Ward 15 13
Ward No 12 12
Ward No 14 12
Ward No. 3 13
Blank 5
Total 918
Table 3: Did the Family Give Consent for the Survey, Jind?
Village/Ward Number
Mundri 1
Roheramajra 1
Arjun Nagar 15
Baata 42
Bala Ji Nagar 20
Balmiki Basti 1
Bittu 1
Chandana Gate 15
Chiranjive Colony 5
Chnadana Gate 1
D.A.V Colony Kaithal 11
Debian Gamdai 1
Employees 19
Hari Nagar 10
Kailram 44
Kaithal 5
Kaul 44
KharakPandwa 44
Khurana Road Ktl 1
Ktl-14 81
LakmhiVihar 11
Majra 18
Mundri 43
Nanakpuri Colony Khurana Road 1
Narar 44
Neem Wala 50
Pabnawa 88
Pintu 1
Pubdri 52
Rajound 32
Rajound 14
Ram Nagar 21
RoheraMajra 25
Saini Maholla 1
SampliKaeri 42
SarpanKheri 1
Sector 20 Kaithal 1
Sector-19 Kaithal 1
Shiv Nagar 20
Sirta Road 18
Table 3: Did the Family Give Consent for the Survey, Kaithal?
Response Number Percent
No 16 1.8
Yes 884 98.2
Total 900 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Kaithal (Multiple
response)
Village/Ward Number
Pabana 1
Popra 4
132001 6
1507 Galino1 Ashok Nagar 1
372 Khatri Mohalla 1
409 But A Singh Colony 22
AlipurViran 44
Anchala 44
Biana 44
BibipurBrahamnan 2
Gagsina 45
Gangatheri 46
Gheer 46
H No 1508 Galino 1 Ashok Nagar 1
KoulKhera 47
Near Baba Lal Das Mandir 12
Near Mata Sundri Mandir 11
Near Panchayat Ghar 15
Near Ravidas Mandir 10
Pabana 42
Popra 45
Uphc Dhobi Mohalla 75
UPHC Indira Colony 104
UPHC Ram Nagar 3
Uphc Shiv Colony 1
Uphc Vasant Vihar 87
Uphcdhobi Mohalla 3
Uphcramanagar 119
VillBibipurBrahamnan 42
Ward No 09 3
Ward No 1 12
Ward No 10 15
Ward No 12 13
Ward No 4 11
Blank 1
Total 978
Table 3: Did the Family Give Consent for the Survey, Karnal?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Karnal (Multiple
response)
Symptoms Number Percent
["No Symptom"] 800 81.8
["Any Other", "No Symptom"] 2 0.2
["Cough", "No Symptom"] 1 0.1
["Cough"] 3 0.3
["Headache", "Tiredness"] 1 0.1
["Sore Throat"] 1 0.1
["Stomach Ache"] 1 0.1
["Tiredness"] 1 0.1
Blank 168 17.1
Total 978 100
Village/Ward Number
KnGamri 2
Krishna Nagar Gamri 1
Majri Mohalla SHAHBAD 14
5 1
7B Hargobind Nagar 1
Babain 44
Baraut 42
Bhorakh 45
Bir Mathana 43
Dd Colony 12
Ekta Vihar 13
Hargobind Nagar 3
Harigarh 46
Jainpue 49
Kishan Pura 47
KnGamri 59
Ladwa 46
Mahuvakheri 44
Majri Mohalla 75
Mathana 45
Royal Resort Road 30
Sanghor 44
Sectoq 5 85
Thaska 1
ThaskaMiranji 44
UphcKnGamri 11
Vashisth Colony 47
Total 894
Village/Ward Number
Bhojawas 2
Anaj Mandi 2
Atali 87
Balayach 43
Bhojawas 40
Chhilro 43
Devilal Colony Mahendergarh 9
Friends Colony 22
Gyarshi Devi 1
House No -5, Shakti Colony 1
Housing Board Hudda 16
Jai Colony 7
Kanina 47
Kath Mandi 19
Mamraj Colony Ward No 2 4
Mohanpur 45
Nangal 45
Nangal Sirohi 42
Nasibpur , Narnaul 1
Nimbhera 43
Nizampur 45
Pawera 41
Rao Tula Colony 22
Shakti Colony 14
Sihma 51
Sobha Sagar 29
Village Bhojawas 1
Ward 10 1
Ward 4 4
Ward 6 3
Ward 8 3
Ward 9 2
Ward 9 Village Bhojawas 4
Ward No 9 1
Ward No 10 2
Ward No 12 1
Ward No 12 Kanina MHN-16 1
Ward No 2 2
Table 7: Was there Any Health Problem in Last 30 Days, Mahendragarh District
Table 3: Did the Family Give Consent for the Survey, Nuh?
Response Number Percent
No. 12 1.4
Yes 871 98.6
Total 883 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Nuh (Multiple response)
Table 3: Did the Family Give Consent for the Survey, Palwal?
Table 7: Was there Any Health Problem in Last 30 Days, Palwal District
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Palwal District
(Multiple response)
Village/Ward Number
BcwSurajpur 4
Chiakn 42
GD Sector 20 172
Kakrali(08) 44
Kharkua 42
Kot 44
Panchkula 1
Pinjore 89
Pkl Sec 26 1
Pkl-03-009 1
R 1
Ratpur Colony 44
Rattewali /Cluster1 42
Sec 26 Panchkula 87
Sector 16 93
Shyamto =Cluster4 43
Surajpur 40
Toda 44
9780816024 1
Blank 1
Total 836
Table 3: Did the Family Give Consent for the Survey, Panchkula?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Panchkula
(Multiple response)
Symptoms Number Percent
["No Symptom"] 644 77
["Body Ache"] 1 0.1
["Cough"] 1 0.1
["Fever", "Body Ache"] 1 0.1
Table 3: Did the Family Give Consent for the Survey, Panipat?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Panipat (Multiple
response)
Symptoms Number Percent
["No Symptom "] 795 90
["Any Other", "No Symptom "] 3 0.3
["Body Ache", "No Symptom "] 1 0.1
["Body Ache"] 1 0.1
["Breathlessness"] 3 0.3
["Cough", "Sore Throat"] 2 0.2
["Cough"] 1 0.1
["Fever", "Sore Throat"] 1 0.1
["Fever"] 5 0.6
["Any Other"] 2 0.2
Blank 69 7.8
Total 883 100
Table 3: Did the Family Give Consent for the Survey, Rewari?
Response Number Percent
No 9 1
Yes 899 99
Total 908 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Rewari (Multiple
response)
Symptoms Number Percent
["No Symptom"] 805 88.7
["Body Ache"] 1 0.1
["Cough", "Sore Throat"] 1 0.1
["Cough"] 1 0.1
["Headache"] 1 0.1
["Running Nose", "Headache"] 1 0.1
["Running Nose"] 3 0.3
["Tiredness"] 1 0.1
["Any Other"] 1 0.1
Blank 93 10.2
Total 908 100
Table 3: Did the Family Give Consent for the Survey, Rohtak?
Response Number Percent
No 58 6.6
Yes 823 93.3
Blank 1 0.1
Total 882 100
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Rohtak (Multiple
response)
Symptoms Number Percent
["No Symptom "] 780 88.4
Blank 102 11.5
Total 882 100
Village/Ward Number
Khairpur 3
Bhagat Singh Colony 1
Burj Karam Gardh 43
Chatergarh Patti 88
Ding 47
Fr Colony 5
Gadli 44
Ghoranwali 44
Gindra 44
Inderpuri 70
Ipm 27
Kabir Basti 1
Kahirpur 1
Karanwala 38
Keharwala 53
KhairPur 98
Kingre 43
Kkhairpur 1
Lpm 1
Mallewaala 42
Mithri 44
Odhan 43
Shakti Nagar 2
Sra 04 Baragudha 36
Srs-08 Mallewala 2
Srs16 1
Ward 17 2
Ward 19 25
Ward 5 22
Ward No 2 4
Ward No 2,Mandi Dabwali 1
Ward No 3 17
Ward No 6 14
Ward No 88 1
Blank 2
Total 910
Table 3: Did the Family Give Consent for the Survey, Sirsa?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Sirsa(Multiple response)
Village/Ward Number
54 1
Adarsh Nagar 1
Anwali 6
Badhoti 41
Barwasni 46
Bashoti 1
Bhagat Singh Colony 10
Bhainswal 42
Chhanoli 44
Dhurana 42
Giwana 27
Hanuman Nag 24
Hulleri 44
Jatwara 11
Jeevan Nagar 23
Kailash Colony 18
Kalupur 13
Lal Darwaja 23
Mahra 45
Matindu 43
Mundlana 42
Patel Nagar 26
Rishi Cly 21
Sec 12 1
Sector 15 1
Shastri Colony Urbmah51 1
Sisana 44
Snpt 1
Snpt -09 27
Snpt- 05 8
Sunder Savri 8
Tara Nagar 19
UhcKalupur 66
Urbmah51 21
Urbmah52 22
Urbmah53 20
Urbmah54 23
Blank 1
Total 857
Table 3: Did the Family Give Consent for the Survey, Sonepat?
Table 8: Did you Get any of the Following Symptoms in Last 30 Days, Sonepat (Multiple
response)
Village/Ward Number
Alahar 44
Arnauli 56
Daulatpur 43
Gandhi Nagar 91
Gumthala 49
Hafizpur 44
Mirzapur 44
Munda Majra 60
Naharpur 44
Rasulpur 43
Ratauli 43
Salempur 30
SalempurBangar 14
Sandhala 40
Sarojini 87
Taranwala 42
Wand -13 67
Ward No 1
Ward No 11 33
Ward No 14 16
Ward No 15 1
Blank 44
Total 936
Table 3: Did the Family Give Consent for the Survey, Yamunanagar?
Table 7: Did you Get any of the Following Symptoms in Last 30 Days, Yamunanagar
(Multiple response)
Ambala 841
Bhiwani 836
Faridabad 823
Fatehabad 860
Gurugram 844
Hisar 856
Jhajjar 848
Jind 869
Kaithal 831
Karnal 855
Kurukshetra 876
Mahendragarh 821
Nuh 888
Palwal 908
Panchkula 873
Panipat 886
Rewari 852
Rohtak 874
Sirsa 901
Sonepat 867
Yamunanagar 818
Total 18905
Faridabad 25.8
Nuh 20.3
Sonepat 13.3
Karnal 12.2
Jind 11.0
Gurugram 10.8
Kurukshetra 8.7
Charkhi Dadri 8.3
Yamunanagar 8.3
Total 8.0
Panipat 7.4
Palwal 7.4
Panchkula 6.5
Jhajjar 5.9
Ambala 5.2
Rewari 4.9
Sirsa 3.6
Hisar 3.4
Fatehabad 3.3
Bhiwani 3.2
Mahendargarh 2.8
Kaithal 1.7
Rohtak 1.1
%
0.0 5.0 10.0 15.0 20.0 25.0 30.0
Table B4: District-wise Seropositivity in Rural and Urban Areas, Haryana, August 2020
Indeterminate
Indeterminate
REJECTED
REJECTED
SAMPLE
SAMPLE
Negative
Negative
Positive
Positive
Total
Total
Ambala N 557 26 0 0 587 230 18 0 0 254
% 94.9% 4.4% 100% 90.6% 7.1% 100%
Bhiwani N 470 19 0 0 489 339 8 0 0 347
% 96.1% 3.9% 100% 97.7% 2.3% 100%
Charkhi Dadri N 476 49 0 0 525 329 24 0 0 353
District-wise and gender-wise seropositivity is shown in table B5. Overall seropositivity was 7.8%
amongst females and 8% among males. Prevalence was among females in district Bhiwani,
Gurugram, Jhajjar, and Mohindergarh. Whereas, it was higher among males in district Hisar, Jind,
Kurukshetra, Nuh, Panipat, and Yamunanagar.
Table B6: District-wise and Cluster-wise Sero positivity in all 22 Districts of Haryana
AMB06 39 3 42 BWN06 42 0 42
AMB07 43 0 44 BWN07 38 2 40
AMB08 37 0 39 BWN08 41 2 43
AMB09 43 3 46 BWN09 37 1 38
AMB10 42 0 42 BWN10 40 0 40
AMB11 45 3 48 BWN11 40 0 40
AMB12 33 2 35 BWN12 37 3 40
AMB13 77 4 83 BWN13 88 1 89
AMB14 74 7 84 BWN14 88 3 91
AMB15 1 0 1 BWN15 82 3 85
AMB16 78 7 86 BWN16 81 1 82
Total 787 44 841 Total 809 27 836
CKDDR01 42 1 43 FBD01 43 8 51
CKDDR02 40 2 42 FBD02 28 8 36
CKDDR03 40 4 44 FBD03 36 5 41
CKDDR04 41 3 44 FBD04 36 3 39
CKDDR05 42 2 44 FBD05 22 9 31
CKDDR06 41 3 44 FBD06 31 11 42
CKDDR07 34 10 44 FBD07 33 9 42
CKDDR08 36 8 44 FBD08 27 19 46
CKDDR09 FBD09 30 10 40
42 2 44
CKDDR10 42 2 44 FBD10 32 8 40
CKDDR11 40 4 44 FBD11 31 10 41
CKDDR12 36 8 44 FBD12 34 9 43
CKDDR13 84 4 88 FBD13 59 21 80
CKDDR14 85 3 88 FBD14 38 47 85
CKDDR15 77 11 88 FBD15 71 15 86
CKDDR16 83 6 89 FBD16 60 20 80
Total 805 73 879 Total 611 212 823